These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5449594)

  • 1. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis.
    Holmes AM; Hesling CM; Wilson TM
    Q J Med; 1970 Apr; 39(154):299-315. PubMed ID: 5449594
    [No Abstract]   [Full Text] [Related]  

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension, hypokalemia, hyporeninemia and severe target organ damage.
    Wilkins GE
    Can Med Assoc J; 1976 Feb; 114(3):241-3. PubMed ID: 147128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 6. [Variations in renin and aldosterone activity in a typical case of Barter syndrome. Influence of anti-aldosterones and sodium intake].
    Zech P; Pozet N; Sassard J; Leitienne P; Blanc N; Colon S; Berthoux F; Touraine JL; Traeger J
    J Urol Nephrol (Paris); 1974 Sep; 80(9):760-5. PubMed ID: 4463254
    [No Abstract]   [Full Text] [Related]  

  • 7. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome.
    Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M
    J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudohyperaldosteronism from liquorice-containing laxatives.
    Scali M; Pratesi C; Zennaro MC; Zampollo V; Armanini D
    J Endocrinol Invest; 1990 Nov; 13(10):847-8. PubMed ID: 2096161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymptomatic chronic hypomagnesemia and hypokalemia in a child: Cell membrane disease.
    Paunier L; Sizonenko PC
    J Pediatr; 1976 Jan; 88(1):51-5. PubMed ID: 1245942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capreomycin-induced serum electrolyte abnormalities.
    Holmes AM; Hesling CM; Wilson TM
    Thorax; 1970 Sep; 25(5):608-11. PubMed ID: 5489186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary hyperaldosteronism--diagnostic approach and management.
    Seshadri MS; Kanagasabapathy AS; Cherian AM; Nair A; Jesudason SR
    J Assoc Physicians India; 1993 May; 41(5):266-8. PubMed ID: 8300455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The occurrence of hyperaldosteronism in infants with congestive heart failure.
    Baylen BG; Johnson G; Tsang R; Srivastava L; Kaplan S
    Am J Cardiol; 1980 Feb; 45(2):305-10. PubMed ID: 6986745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).
    Salti IS; Stiefel M; Ruse JL; Laidlaw JC
    Can Med Assoc J; 1969 Jul; 101(1):1-10. PubMed ID: 5793351
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: On the role of diuretic-and spironolactone-induced hyperaldosteronism on electrolyte excretion in man.
    Erbler H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R19. PubMed ID: 4276539
    [No Abstract]   [Full Text] [Related]  

  • 18. I. Measurement of sweat sodium and potassium excretion for evaluation of mineralocorticoid activity in normal subjects.
    Grandchamp A; Scherrer JR; Veyrat R; Muller AF
    Helv Med Acta; 1969 Jan; 34(5):367-85. PubMed ID: 5766168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life-threatening hypokalaemia on a low-carbohydrate diet associated with previously undiagnosed primary hyperaldosteronism [corrected].
    Advani A; Taylor R
    Diabet Med; 2005 Nov; 22(11):1605-7. PubMed ID: 16241928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.